Literature DB >> 2787823

IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells.

G Marone1, V Casolaro, R Paganelli, I Quinti.   

Abstract

IgG antibodies containing anti-IgE activity isolated from a patient with atopic dermatitis (H-aIgE) induced mediator release from human basophils and mast cells isolated from skin and lung tissues. The release of histamine was calcium- and temperature-dependent and did not involve cytotoxicity. There was an excellent correlation (r = 0.88; p less than 0.001) between the maximum percent histamine release from human basophils induced by rabbit anti-IgE (R-aIgE) and H-aIgE. H-aIgE was approximately 30 times more potent than R-aIgE in inducing mediator release from human basophils, skin, and lung mast cells. H-aIgE specifically desensitized human basophils to a subsequent challenge with both H-aIgE and R-aIgE. Lactic acid removal of IgE from human basophils blocked the releasing activity of both R-aIgE and H-aIgE. Passive sensitization with hyperimmune sera or purified IgE myeloma restored the response of basophils to both R-aIgE and H-aIgE. IgE purified from three different myeloma patients concentration-dependently blocked the histamine releasing activity of both R-aIgE and H-aIgE.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787823     DOI: 10.1111/1523-1747.ep12277582

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  Nonspecific histamine-releasing properties of general anesthetic drugs.

Authors:  G Marone; C Stellato; P Mastronardi; B Mazzarella
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

2.  High IgE in rheumatoid arthritis (RA) patients is complexed with anti-IgE autoantibodies.

Authors:  N Millauer; A W Zuercher; S M Miescher; H A Gerber; M Seitz; B M Stadler
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 3.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

4.  Studies on the association between immunoglobulin E autoreactivity and immunoglobulin E-dependent histamine-releasing factors.

Authors:  Ilona Kleine Budde; Pleuni G de Heer; Susanne Natter; Vera Mahler; Jaring S van der Zee; Rudolf Valenta; Rob C Aalberse
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

5.  Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?

Authors:  E Fiebiger; D Maurer; H Holub; B Reininger; G Hartmann; M Woisetschläger; J P Kinet; G Stingl
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Immunological modulation of human cardiac mast cells.

Authors:  G Marone; G de Crescenzo; G Florio; F Granata; V Dente; A Genovese
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

7.  Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells.

Authors:  Remo Poto; Vincenzo Patella; Gjada Criscuolo; Gianni Marone; Enrico Coscioni; Gilda Varricchi
Journal:  Clin Exp Med       Date:  2022-07-25       Impact factor: 5.057

8.  IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells.

Authors:  Remo Poto; Isabella Quinti; Gianni Marone; Maurizio Taglialatela; Amato de Paulis; Vincenzo Casolaro; Gilda Varricchi
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

Review 9.  Autoimmune urticaria.

Authors:  Malcolm Greaves
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 10.  Human heart as a shock organ in anaphylaxis.

Authors:  Gianni Marone; Arturo Genovese; Gilda Varricchi; Francescopaolo Granata
Journal:  Allergo J Int       Date:  2014-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.